Logo
x

Search

Subscribe Now

Jacobio

Jacobio Entered into a Clinical Collaboration with Merck to Evaluate JAB-BX102 + Keytruda (pembrolizumab) for Solid Tumors

Jacobio Entered into a Clinical Collaboration with Merck to Evaluate JAB-BX102 + Keytruda (pembrolizumab) for Solid Tumors

  • March 22, 2023
Jacobio Reports the Completion of First Patient Dosing of JAB-21822 + Cetuximab in Clinical Trials for the Treatment of Colorectal Cancer

Jacobio Reports the Completion of First Patient Dosing of JAB-21822 + Cetuximab in Clinical Trials for the Treatment of Colorectal...

  • February 24, 2022
PharmaShots Weekly Snapshots (March 20 - 24, 2023)

    PharmaShots Weekly Snapshots (March 20 - 24, 2023)

    • March 24, 2023
    Jacobio Entered into a Clinical Collaboration with Merck to Evaluate JAB-BX102 + Keytruda (pembrolizumab) for Solid Tumors

      Jacobio Entered into a Clinical Collaboration with Merck to Evaluate JAB-BX102 + Keytruda (pembrolizumab) for Solid Tumors

      • March 22, 2023
      PharmaShots Weekly Snapshots (February 21-25, 2022)

        PharmaShots Weekly Snapshots (February 21-25, 2022)

        • February 25, 2022
        Jacobio Reports the Completion of First Patient Dosing of JAB-21822 + Cetuximab in Clinical Trials for the Treatment of Colorectal Cancer

          Jacobio Reports the Completion of First Patient Dosing of JAB-21822 + Cetuximab in Clinical Trials for the Treatment of Colorectal...

          • February 24, 2022
          PharmaShots Weekly Snapshots (December 06-10, 2021)

            PharmaShots Weekly Snapshots (December 06-10, 2021)

            • December 10, 2021
            Jacobio Receives CDE’s IND Approval for Combination Therapy of KRAS G12C and Cetuximab Injection in China

              Jacobio Receives CDE’s IND Approval for Combination Therapy of KRAS G12C and Cetuximab Injection in China

              • December 6, 2021
              Image

              Incisive News in 3 Shots.

              Contact Us

              Our Information

              Follow Us

              Copyright © 2025 PharmaShots - All Rights Reserved.